Sort   by:  
 Page size 
UnknownComparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform.
Not available
S-EPMC8865947 | biostudies-literature
UnknownInitial Invasive or Conservative Strategy for Stable Coronary Disease.
Not available
S-EPMC7263833 | biostudies-literature
UnknownReactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Not available
S-EPMC8409975 | biostudies-literature
UnknownHeterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy.
Not available
S-EPMC6556837 | biostudies-literature
UnknownA multi-country analysis of COVID-19 hospitalizations by vaccination status.
Not available
S-EPMC10935543 | biostudies-literature
UnknownGenetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data.
Not available
S-EPMC4392068 | biostudies-literature
UnknownEffect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC7653542 | biostudies-literature
UnknownSafety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Not available
S-EPMC7674972 | biostudies-literature
UnknownTherapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594 | biostudies-literature
UnknownBiallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.
Not available
S-EPMC10932913 | biostudies-literature
Sort   by:  
 Page size